Cargando…

Early detection of tumour immune-rejection using magnetic resonance imaging

Dynamic contrast agent-enhanced magnetic resonance imaging measurements of the perfusion of an immunogenic murine tumour showed that immune rejection was preceded by an increase in the apparent vascular volume of the tumour. This increase in vascularity, which has been observed previously in other t...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, D-E, Beauregard, D A, Bearchell, M C, Thomsen, L L, Brindle, K M
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2003
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2376373/
https://www.ncbi.nlm.nih.gov/pubmed/12671716
http://dx.doi.org/10.1038/sj.bjc.6600814
Descripción
Sumario:Dynamic contrast agent-enhanced magnetic resonance imaging measurements of the perfusion of an immunogenic murine tumour showed that immune rejection was preceded by an increase in the apparent vascular volume of the tumour. This increase in vascularity, which has been observed previously in other tumours undergoing immune rejection, was confirmed by histological analysis of tumour sections obtained postmortem. Magnetic resonance imaging measurements similar to this could be used in the clinic to monitor the early responses of tumours to immunotherapy, before there is any change in tumour growth rate or volume.